These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29635210)

  • 1. Evaluation of the Architect HIV Ag/Ab Combo Assay in a low-prevalence setting: The role of samples with a low S/CO ratio.
    Alonso R; Pérez-García F; Gijón P; Collazos A; Bouza E
    J Clin Virol; 2018 Jun; 103():43-47. PubMed ID: 29635210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
    Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
    J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting.
    Chacón L; Mateos ML; Holguín Á
    J Clin Virol; 2017 Jul; 92():11-13. PubMed ID: 28501753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample-to-cutoff ratios using Architect HIV Ag/Ab Combo: The influence with the results of supplemental tests and optimal cutoff value to predict HIV infection.
    Wang L; Wang JY; Tian XD; Ruan JX; Yu Y; Yan F
    J Clin Lab Anal; 2019 Jun; 33(5):e22866. PubMed ID: 30803030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy.
    Adhikari EH; Macias D; Gaffney D; White S; Rogers VL; McIntire DD; Roberts SW
    Am J Obstet Gynecol; 2018 Oct; 219(4):408.e1-408.e9. PubMed ID: 29913173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
    Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
    J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Optimal Cutoff Value to Predict HIV Infection Using the Architect HIV Ag/Ab Combo.
    Zhang X; Zhou X; He X; Liu X; Wang Z
    Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
    Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting.
    Jensen TO; Robertson P; Whybin R; Chambers I; Lahra M; Rawlinson W; Post JJ
    J Clin Microbiol; 2015 May; 53(5):1709-11. PubMed ID: 25673794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection in Xi'an, China: epidemic characterization, risk factors to false positives and potential utility of the sample-to-cutoff index to identify true positives using Architect HIV Ag/Ab combo.
    Wang L; Xiao Y; Tian XD; Ruan JX; Chen W; Yu Y
    Antimicrob Resist Infect Control; 2019; 8():9. PubMed ID: 30651975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
    Dubravac T; Gahan TF; Pentella MA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and diagnostic testing protocols for HIV and Syphilis infections in health care setting in Qatar: Evaluation and recommendations.
    Nasrallah GK; Al-Buainain R; Younes N; Dargham SR; Al-Sadeq DW; Elhassan M; Al-Shaar I; Yassine HM; Abu-Raddad LJ; Emara MM; Ismail A
    PLoS One; 2023; 18(2):e0278079. PubMed ID: 36749795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infection.
    Curtis KA; Rudolph DL; Pan Y; Delaney K; Anastos K; DeHovitz J; Kassaye SG; Hanson CV; French AL; Golub E; Adimora AA; Ofotokun I; Bolivar H; Kempf MC; Peters PJ; Switzer WM
    PLoS One; 2021; 16(7):e0242641. PubMed ID: 34197451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay.
    Kfutwah A; Lemée V; Ngono HV; De Oliveira F; Njouom R; Plantier JC
    J Clin Virol; 2013 Dec; 58 Suppl 1():e70-5. PubMed ID: 24342480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical performance evaluation and enhancement of the ADVIA Centaur® HIV Ag/Ab Combo assay.
    Demey B; Usureau C; Boillod P; Bodeau S; François C; Roussel C; Duverlie G; Castelain S; Brochot E
    J Clin Virol; 2019 Sep; 118():36-40. PubMed ID: 31415958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens.
    Qiu X; Sokoll L; Yip P; Elliott DJ; Dua R; Mohr P; Wang XY; Spencer M; Swanson P; Dawson GJ; Hackett J
    J Clin Virol; 2017 Jul; 92():62-68. PubMed ID: 28535437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination between recent and non-recent HIV infections using routine diagnostic serological assays.
    Hassan J; Moran J; Murphy G; Mason O; Connell J; De Gascun C
    Med Microbiol Immunol; 2019 Oct; 208(5):693-702. PubMed ID: 30859301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.